115 related articles for article (PubMed ID: 11230738)
1. Bile acids induce eosinophil degranulation by two different mechanisms.
Yamazaki K; Gleich GJ; Kita H
Hepatology; 2001 Mar; 33(3):582-90. PubMed ID: 11230738
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
[TBL] [Abstract][Full Text] [Related]
3. Secretory IgA induces antigen-independent eosinophil survival and cytokine production without inducing effector functions.
Bartemes KR; Cooper KM; Drain KL; Kita H
J Allergy Clin Immunol; 2005 Oct; 116(4):827-35. PubMed ID: 16210057
[TBL] [Abstract][Full Text] [Related]
4. Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat.
Roda A; Piazza F; Baraldini M; Speroni E; Guerra MC; Cerré C; Cantelli Forti G
Hepatology; 1998 Feb; 27(2):520-5. PubMed ID: 9462652
[TBL] [Abstract][Full Text] [Related]
5. Chenodeoxycholic acid and taurochenodexycholic acid induce anti-apoptotic cIAP-1 expression in human hepatocytes.
Hirano F; Haneda M; Makino I
J Gastroenterol Hepatol; 2006 Dec; 21(12):1807-13. PubMed ID: 17074018
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
[TBL] [Abstract][Full Text] [Related]
7. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver.
Wimmer R; Hohenester S; Pusl T; Denk GU; Rust C; Beuers U
Gut; 2008 Oct; 57(10):1448-54. PubMed ID: 18583398
[TBL] [Abstract][Full Text] [Related]
8. Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils.
Okada S; Hagan JB; Kato M; Bankers-Fulbright JL; Hunt LW; Gleich GJ; Kita H
J Immunol; 1998 Apr; 160(8):4010-7. PubMed ID: 9558110
[TBL] [Abstract][Full Text] [Related]
9. Interaction of IL 1 and TPA in modulation of eosinophil function.
Pincus SH; Whitcomb EA; Dinarello CA
J Immunol; 1986 Dec; 137(11):3509-14. PubMed ID: 3023484
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix proteins attenuate activation and degranulation of stimulated eosinophils.
Kita H; Horie S; Gleich GJ
J Immunol; 1996 Feb; 156(3):1174-81. PubMed ID: 8557995
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-12 inhibits eosinophil degranulation and migration but does not promote eosinophil apoptosis.
Davoine F; Ferland C; Chakir J; Lee JE; Adamko DJ; Moqbel R; Laviolette M
Int Arch Allergy Immunol; 2006; 140(4):277-84. PubMed ID: 16735797
[TBL] [Abstract][Full Text] [Related]
12. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver.
Beuers U; Bilzer M; Chittattu A; Kullak-Ublick GA; Keppler D; Paumgartner G; Dombrowski F
Hepatology; 2001 May; 33(5):1206-16. PubMed ID: 11343250
[TBL] [Abstract][Full Text] [Related]
13. German cockroach extract induces activation of human eosinophils to release cytotoxic inflammatory mediators.
Sohn MH; Lee YA; Jeong KY; Sim S; Kim KE; Yong TS; Shin MH
Int Arch Allergy Immunol; 2004 Jun; 134(2):141-9. PubMed ID: 15153794
[TBL] [Abstract][Full Text] [Related]
14. Bile acid transport and regulating functions in the human biliary epithelium.
Chignard N; Mergey M; Veissière D; Parc R; Capeau J; Poupon R; Paul A; Housset C
Hepatology; 2001 Mar; 33(3):496-503. PubMed ID: 11230727
[TBL] [Abstract][Full Text] [Related]
15. Taurine chloramine inhibits functional responses of human eosinophils in vitro.
Martinez-Losa M; Cortijo J; Piqueras L; Sanz MJ; Morcillo EJ
Clin Exp Allergy; 2009 Apr; 39(4):537-46. PubMed ID: 19222497
[TBL] [Abstract][Full Text] [Related]
16. Cytokines directly induce degranulation and superoxide production from human eosinophils.
Horie S; Gleich GJ; Kita H
J Allergy Clin Immunol; 1996 Aug; 98(2):371-81. PubMed ID: 8757214
[TBL] [Abstract][Full Text] [Related]
17. Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions.
Sedgwick JB; Jansen KJ; Kennedy JD; Kita H; Busse WW
J Allergy Clin Immunol; 2005 Oct; 116(4):812-9. PubMed ID: 16210055
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen.
Clark K; Simson L; Newcombe N; Koskinen AM; Mattes J; Lee NA; Lee JJ; Dent LA; Matthaei KI; Foster PS
J Leukoc Biol; 2004 Jun; 75(6):1001-9. PubMed ID: 15020648
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (pranlukast; ONO-1078).
Suzuki M; Kato M; Kimura H; Fujiu T; Morikawa A
J Asthma; 2003 Jun; 40(4):395-404. PubMed ID: 12870835
[TBL] [Abstract][Full Text] [Related]
20. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes.
Dent P; Fang Y; Gupta S; Studer E; Mitchell C; Spiegel S; Hylemon PB
Hepatology; 2005 Dec; 42(6):1291-9. PubMed ID: 16317705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]